When Pancreatic Cysts Need Closer Attention: Study Links Multiple Warning Signs to Higher Cancer Risk
- 1 day ago
- 3 min read
Chhoda A, Carlson EE, Bamlet WR, et al. Clinical Outcomes in Patients with Worrisome and High-Risk Pancreatic Cysts: A Prospective Cohort Study. Gastroenterology. Published online August 20, 2026. DOI: 10.1053/j.gastro.2026.07.038.
Pancreatic cysts are common and are often discovered unexpectedly during imaging for another health concern. Most never become cancerous, but some contain features that may indicate a greater risk of developing pancreatic cancer or advanced precancerous changes. Determining which cysts require surgery and which can be safely monitored remains a significant challenge.
A new prospective study from Mayo Clinic suggests that the number of concerning features present in a pancreatic cyst may help physicians estimate that risk more accurately.
What Did the Study Examine?
Researchers followed 230 patients whose pancreatic cysts had at least one “worrisome” or “high-risk” feature. These are findings identified through imaging, symptoms, or other evaluations that may suggest a cyst requires closer monitoring or treatment.
Unlike many earlier studies that reviewed existing medical records or primarily included people who underwent surgery, this study enrolled patients and followed them over time.
This allowed researchers to observe outcomes among patients who had surgery as well as those whose cysts were monitored.
Of the 230 participants:
32 underwent surgery within three months of entering the study.
198 entered clinical surveillance.
Among those monitored, 185 had cysts with worrisome features and 13 had cysts considered high-risk.
During follow-up, 18 additional patients underwent surgery.
The patients were followed for nearly three years.
What Did Researchers Find?
The likelihood of developing pancreatic cancer or an advanced precancerous condition increased as the number of concerning features increased:
One concerning feature: approximately 2% risk within three years
Two concerning features: approximately 4% risk
Three or more concerning features: approximately 18% risk
Among the patients who underwent surgery during surveillance, pathology identified one case of high-grade dysplasia—an advanced precancerous change—and two stage IA pancreatic cancers arising from intraductal papillary mucinous neoplasms, or IPMNs.
Importantly, the cancers found during surveillance were detected at an early stage. This suggests that carefully planned monitoring may provide an opportunity to identify concerning changes early in appropriately selected patients.
Why Does This Research Matter?
A pancreatic cyst does not automatically mean that a person has—or will develop—pancreatic cancer. The study found that patients with only one worrisome feature generally had a relatively low risk of progression over three years. However, the risk increased considerably when several concerning features occurred together.
These findings may help patients and physicians have more informed conversations about whether to continue surveillance or consider surgery. Pancreatic surgery is a major procedure with meaningful risks, so avoiding unnecessary operations is important. At the same time, identifying patients whose cysts are more likely to progress could allow treatment before cancer becomes advanced.
The results also reinforce that risk should not be determined by one finding alone. Physicians consider the type and number of cyst features, changes over time, symptoms, age, overall health, family history, and whether the patient can safely undergo surgery.
What Are the Study’s Limitations?
This was a relatively small study conducted at a single medical center, and the follow-up period was approximately three years. Because few participants developed advanced precancerous changes or cancer, researchers could not determine which individual worrisome features were most strongly associated with progression.
Larger studies conducted at multiple centers—and with longer follow-up—are needed to confirm the risk estimates and determine whether certain features are especially important.
The findings do not establish a new universal threshold for surgery. Rather, they provide additional information that specialists may use alongside existing clinical guidelines and each patient’s individual circumstances.
What Does This Mean for Patients?
For patients with pancreatic cysts, the main message is reassuring: most cysts do not become cancerous, and the presence of one worrisome feature does not necessarily mean that immediate surgery is needed. However, cysts with several concerning features may require more intensive monitoring, additional testing, or a discussion about surgical treatment.
Patients may want to ask their healthcare team:
What type of pancreatic cyst do I have?
Does my cyst have any worrisome or high-risk features?
How many concerning features are present?
How often should the cyst be monitored?
What changes would lead you to recommend additional testing or surgery?
Should my case be reviewed by a multidisciplinary team experienced in pancreatic cysts and pancreatic cancer?
The Bottom Line
This study suggests that the accumulation of concerning features—not simply the presence of a single finding—may be an important indicator of pancreatic cyst progression. Patients with one concerning feature had a relatively low three-year risk, while those with three or more had a substantially higher risk.
Although additional research is needed, these findings could support more personalized care: helping higher-risk patients receive earlier intervention while allowing lower-risk patients to avoid unnecessary surgery and continue appropriate surveillance.
